1. Home
  2. ONCO vs IMTE Comparison

ONCO vs IMTE Comparison

Compare ONCO & IMTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONCO
  • IMTE
  • Stock Information
  • Founded
  • ONCO 2018
  • IMTE 2008
  • Country
  • ONCO United States
  • IMTE Malaysia
  • Employees
  • ONCO N/A
  • IMTE N/A
  • Industry
  • ONCO Biotechnology: Pharmaceutical Preparations
  • IMTE Consumer Electronics/Appliances
  • Sector
  • ONCO Health Care
  • IMTE Consumer Staples
  • Exchange
  • ONCO Nasdaq
  • IMTE Nasdaq
  • Market Cap
  • ONCO 4.7M
  • IMTE 3.8M
  • IPO Year
  • ONCO 2022
  • IMTE N/A
  • Fundamental
  • Price
  • ONCO $3.79
  • IMTE $0.92
  • Analyst Decision
  • ONCO
  • IMTE
  • Analyst Count
  • ONCO 0
  • IMTE 0
  • Target Price
  • ONCO N/A
  • IMTE N/A
  • AVG Volume (30 Days)
  • ONCO 65.4K
  • IMTE 54.8K
  • Earning Date
  • ONCO 12-09-2025
  • IMTE 09-26-2025
  • Dividend Yield
  • ONCO N/A
  • IMTE N/A
  • EPS Growth
  • ONCO N/A
  • IMTE N/A
  • EPS
  • ONCO N/A
  • IMTE N/A
  • Revenue
  • ONCO $1,326,959.00
  • IMTE $123,337.00
  • Revenue This Year
  • ONCO N/A
  • IMTE N/A
  • Revenue Next Year
  • ONCO N/A
  • IMTE N/A
  • P/E Ratio
  • ONCO N/A
  • IMTE N/A
  • Revenue Growth
  • ONCO N/A
  • IMTE 4.75
  • 52 Week Low
  • ONCO $2.45
  • IMTE $0.51
  • 52 Week High
  • ONCO $305.15
  • IMTE $3.17
  • Technical
  • Relative Strength Index (RSI)
  • ONCO 55.84
  • IMTE 43.28
  • Support Level
  • ONCO $3.48
  • IMTE $0.95
  • Resistance Level
  • ONCO $3.65
  • IMTE $1.05
  • Average True Range (ATR)
  • ONCO 0.21
  • IMTE 0.06
  • MACD
  • ONCO -0.01
  • IMTE -0.01
  • Stochastic Oscillator
  • ONCO 39.18
  • IMTE 40.83

About ONCO Onconetix Inc.

Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.

About IMTE Integrated Media Technology Limited

Integrated Media Technology Ltd is engaged in the development, sale, and distribution of autostereoscopic 3D display, 3D conversion equipment, and software, development, and sale of 3D autostereoscopic technology, and the provision of 3D consultancy services. It operates through the following segments: the sale of electronic glass, sales of air-filter products, sales of Halal products, NFT, corporate, provision of consultancy and provision of new energy products and solutions.

Share on Social Networks: